These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36293372)

  • 21. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.
    Wang S; Pudney J; Song J; Mor G; Schwartz PE; Zheng W
    Gynecol Oncol; 2003 Feb; 88(2):108-17. PubMed ID: 12586588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin attenuates the production and proliferative effects of prolactin induced by medroxyprogesterone acetate during fertility-sparing treatment for endometrial cancer.
    Gu W; Mitsuhashi A; Kobayashi T; Shozu M
    BMC Cancer; 2022 Jul; 22(1):753. PubMed ID: 35820883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetate regulates milk fat synthesis through the mammalian target of rapamycin/eukaryotic initiation factor 4E signaling pathway in bovine mammary epithelial cells.
    Zhao Y; Guo X; Yan S; Shi B; Sheng R
    J Dairy Sci; 2021 Jan; 104(1):337-345. PubMed ID: 33189285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas.
    Shoji K; Oda K; Kashiyama T; Ikeda Y; Nakagawa S; Sone K; Miyamoto Y; Hiraike H; Tanikawa M; Miyasaka A; Koso T; Matsumoto Y; Wada-Hiraike O; Kawana K; Kuramoto H; McCormick F; Aburatani H; Yano T; Kozuma S; Taketani Y
    PLoS One; 2012; 7(5):e37431. PubMed ID: 22662154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro.
    Darb-Esfahani S; Faggad A; Noske A; Weichert W; Buckendahl AC; Müller B; Budczies J; Röske A; Dietel M; Denkert C
    J Cancer Res Clin Oncol; 2009 Jul; 135(7):933-41. PubMed ID: 19107520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
    Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
    Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
    Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progestin treatment decreases CD133+ cancer stem cell populations in endometrial cancer.
    Guy MS; Qamar L; Behbakht K; Post MD; Sheeder J; Sartorius CA; Spillman MA
    Gynecol Oncol; 2016 Mar; 140(3):518-26. PubMed ID: 26731726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of long non-coding HOTAIR enhances the sensitivity to progesterone in endometrial cancer by epigenetic regulation of progesterone receptor isoform B.
    Chi S; Liu Y; Zhou X; Feng D; Xiao X; Li W; Zhao Y; Wang H
    Cancer Chemother Pharmacol; 2019 Feb; 83(2):277-287. PubMed ID: 30443761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amentoflavone promotes ferroptosis by regulating reactive oxygen species (ROS) /5'AMP-activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR) to inhibit the malignant progression of endometrial carcinoma cells.
    Sun Q; Zhen P; Li D; Liu X; Ding X; Liu H
    Bioengineered; 2022 May; 13(5):13269-13279. PubMed ID: 35635082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression.
    Jiang Y; Chen X; Wei Y; Feng Y; Zheng W; Zhang Z
    Biomed Pharmacother; 2019 May; 113():108712. PubMed ID: 30849641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of PDCD4 induced by progesterone is mediated by the PI3K/AKT signaling pathway in human endometrial cancer cells.
    Wang X; Li Y; Wan L; Liu Y; Sun Y; Liu Y; Shi Y; Zhang L; Zhou H; Wang J; Wang X; Wei Z
    Oncol Rep; 2019 Aug; 42(2):849-856. PubMed ID: 31233196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MNK2 inhibits eIF4G activation through a pathway involving serine-arginine-rich protein kinase in skeletal muscle.
    Hu SI; Katz M; Chin S; Qi X; Cruz J; Ibebunjo C; Zhao S; Chen A; Glass DJ
    Sci Signal; 2012 Feb; 5(211):ra14. PubMed ID: 22337810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a.
    Ma AY; Xie SW; Zhou JY; Zhu Y
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FKBP38 suppresses endometrial cancer cell proliferation and metastasis by inhibiting the mTOR pathway.
    Yan Y; Wang S; Zhang Z; Tang M; Zhao AZ; Li Z; Wu X; Li F
    Arch Biochem Biophys; 2024 Feb; 752():109891. PubMed ID: 38218360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.